{"id":946504,"date":"2025-11-01T13:11:18","date_gmt":"2025-11-01T13:11:18","guid":{"rendered":"https:\/\/ukpostcode.org\/content\/?p=946504"},"modified":"2025-11-01T13:11:18","modified_gmt":"2025-11-01T13:11:18","slug":"the-rise-of-fridge-free-vaccines-trials-in-the-uk","status":"publish","type":"post","link":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/","title":{"rendered":"The Rise of Fridge-Free Vaccines: Trials in the UK"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_73 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#Stablepharma_Ltds_%E2%80%9CFridge-Free%E2%80%9D_Vaccine_Trials_in_the_UK\" title=\"Stablepharma Ltd\u2019s \u201cFridge-Free\u201d Vaccine Trials in the UK\">Stablepharma Ltd\u2019s \u201cFridge-Free\u201d Vaccine Trials in the UK<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#What_is_happening\" title=\"What is happening\">What is happening<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#Why_it_matters\" title=\"Why it matters\">Why it matters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#Key_details_and_metrics\" title=\"Key details and metrics\">Key details and metrics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#What_to_watch_next_steps\" title=\"What to watch \/ next steps\">What to watch \/ next steps<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#Comments_reflections\" title=\"Comments &amp; reflections\">Comments &amp; reflections<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#Final_summary\" title=\"Final summary\">Final summary<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#Case_Study_1_Stablepharma_Ltd_%E2%80%93_SPVX02_Tetanus_Diphtheria\" title=\"Case Study 1: Stablepharma Ltd \u2013 SPVX02 (Tetanus &amp; Diphtheria)\">Case Study 1: Stablepharma Ltd \u2013 SPVX02 (Tetanus &amp; Diphtheria)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#Case_Study_2_Regional_Infrastructure_Lens_%E2%80%93_UK_Government-backed_Programme_Cold_Chain_Disruption\" title=\"Case Study 2: Regional \/ Infrastructure Lens \u2013 UK Government-backed Programme &amp; Cold Chain Disruption\">Case Study 2: Regional \/ Infrastructure Lens \u2013 UK Government-backed Programme &amp; Cold Chain Disruption<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#Commentary_%E2%80%93_What_the_Rise_of_Fridge-Free_Vaccines_Means\" title=\"Commentary \u2013 What the Rise of Fridge-Free Vaccines Means\">Commentary \u2013 What the Rise of Fridge-Free Vaccines Means<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#Final_Take-away\" title=\"Final Take-away\">Final Take-away<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Stablepharma_Ltds_%E2%80%9CFridge-Free%E2%80%9D_Vaccine_Trials_in_the_UK\"><\/span>Stablepharma Ltd\u2019s \u201cFridge-Free\u201d Vaccine Trials in the UK<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><img decoding=\"async\" src=\"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/static.wixstatic.com\/media\/178f68_a827da6528d14e75826b4b30c120184f~mv2.jpg\/v1\/crop\/x_0%2Cy_182%2Cw_5581%2Ch_3357\/fill\/w_280%2Ch_138%2Cal_c%2Cq_80%2Cusm_0.66_1.00_0.01%2Cenc_avif%2Cquality_auto\/IMG_0855%201.jpg\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ars.els-cdn.com\/content\/image\/1-s2.0-S0264410X23004310-gr1.jpg\" alt=\"Image\" \/><\/p>\n<p>Here\u2019s a detailed breakdown of the development and significance of fridge-free vaccines in the UK.<\/p>\n<hr \/>\n<h3><span class=\"ez-toc-section\" id=\"What_is_happening\"><\/span>What is happening<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li>Stablepharma has developed a lead vaccine candidate, SPVX02, a tetanus-&amp;-diphtheria (Td) booster, reformulated using its proprietary platform (StablevaX\u2122) into a <em>thermostable<\/em> vaccine that does <strong>not<\/strong> require continuous refrigeration. (<a title=\"Stablepharma Receives MHRA Approval for Phase 1 Trial of Fridge-Free Tetanus &amp; Diphtheria (Td) Vaccine - Stablepharma\" href=\"https:\/\/stablepharma.com\/stablepharma-receives-mhra-approval-phase-1-trial-of-fridge-free-td-vaccine\/?utm_source=chatgpt.com\">Stablepharma<\/a>)<\/li>\n<li>The UK regulatory body Medicines and Healthcare products Regulatory Agency (MHRA) granted approval for a <strong>Phase 1 first-in-human clinical trial<\/strong> in the UK. (<a title=\"Stablepharma\u2019s fridge-free vaccine entering first-in-human UK clinical trial | BIA\" href=\"https:\/\/www.bioindustry.org\/resource\/stablepharma-s-fridge-free-vaccine-entering-first-in-human-uk-clinical-trial.html?utm_source=chatgpt.com\">bioindustry.org<\/a>)<\/li>\n<li>The trial is run at the NIHR Southampton Clinical Research Facility (University Hospital Southampton) under lead investigator Saul Faust and Stablepharma\u2019s CDO Karen O\u2019Hanlon. (<a title=\"World-first clinical trial launched in Southampton for a fridge-free vaccine | ITV News Meridian\" href=\"https:\/\/www.itv.com\/news\/meridian\/2025-04-28\/world-first-clinical-trial-launched-in-the-uk-for-a-fridge-free-vaccine?utm_source=chatgpt.com\">ITVX<\/a>)<\/li>\n<li>The first participant was dosed in April 2025 (for example, 15 April 2025) and the trial is expected to complete in Q3 2025, with results by end of year. (<a title=\"UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus &amp; Diphtheria Vaccine - BioSpace\" href=\"https:\/\/www.biospace.com\/press-releases\/uk-company-stablepharma-ltd-enters-phase-1-clinical-trials-with-world-first-fridge-free-tetanus-diphtheria-vaccine?utm_source=chatgpt.com\">BioSpace<\/a>)<\/li>\n<li>Prior to this, Stablepharma had shown in stability studies that SPVX02 remained fully potent after exposure to extreme temperature fluctuations (-20 \u00b0C up to +40 \u00b0C) and claimed a shelf-life at room temperature for the clinical batch. (<a title=\"UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus &amp; Diphtheria Vaccine - BioSpace\" href=\"https:\/\/www.biospace.com\/press-releases\/uk-company-stablepharma-ltd-enters-phase-1-clinical-trials-with-world-first-fridge-free-tetanus-diphtheria-vaccine?utm_source=chatgpt.com\">BioSpace<\/a>)<\/li>\n<li>They claim their technology could be applied to <em>up to 60 other vaccines<\/em> which currently rely on a cold-chain. (<a title=\"World-first clinical trial launched in the UK for a fridge-free vaccine | The Standard\" href=\"https:\/\/www.standard.co.uk\/news\/science\/health-southampton-world-health-organisation-university-of-southampton-wes-streeting-b1224818.html?utm_source=chatgpt.com\">The Standard<\/a>)<\/li>\n<\/ul>\n<hr \/>\n<h3><span class=\"ez-toc-section\" id=\"Why_it_matters\"><\/span>Why it matters<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li><strong>Cold-chain reduction<\/strong>: Vaccines typically require storage at 2\u20138 \u00b0C or even lower in some cases. The requirement for refrigeration\/frozen transport makes distribution costly, energy intensive, and risky (storage failures \u2192 wastage). The WHO estimates up to ~50% of vaccines are wasted annually (globally) partly due to cold-chain failures. (<a title=\"World-first clinical trial launched in Southampton for a fridge-free vaccine | ITV News Meridian\" href=\"https:\/\/www.itv.com\/news\/meridian\/2025-04-28\/world-first-clinical-trial-launched-in-the-uk-for-a-fridge-free-vaccine?utm_source=chatgpt.com\">ITVX<\/a>)<\/li>\n<li><strong>Access in low-resource settings<\/strong>: A vaccine that can be stored at ambient\/room temperature dramatically improves reach in remote, rural or low-income regions where constant refrigeration is difficult. That can enhance immunisation coverage, equity and global health impact.<\/li>\n<li><strong>Cost savings &amp; carbon footprint<\/strong>: Reducing reliance on refrigeration and cold transport reduces logistics cost, energy use and CO\u2082 emissions\u2014an added sustainability benefit. (<a title=\"UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus &amp; Diphtheria Vaccine - BioSpace\" href=\"https:\/\/www.biospace.com\/press-releases\/uk-company-stablepharma-ltd-enters-phase-1-clinical-trials-with-world-first-fridge-free-tetanus-diphtheria-vaccine?utm_source=chatgpt.com\">BioSpace<\/a>)<\/li>\n<li><strong>UK biotechnology leadership<\/strong>: The trial being the \u201cworld-first\u201d human trial of a fridge-free vaccine positions the UK as a leader in this niche of vaccine innovation. Public funding and regulatory support underline this. (<a title=\"World-first clinical trial launched in the UK for a fridge-free vaccine | The Standard\" href=\"https:\/\/www.standard.co.uk\/news\/science\/health-southampton-world-health-organisation-university-of-southampton-wes-streeting-b1224818.html?utm_source=chatgpt.com\">The Standard<\/a>)<\/li>\n<\/ul>\n<hr \/>\n<h3><span class=\"ez-toc-section\" id=\"Key_details_and_metrics\"><\/span>Key details and metrics<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<th>Parameter<\/th>\n<th>Value \/ detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Technology platform<\/td>\n<td>StablevaX\u2122 \u2013 reformulates existing\/new vaccines into thermostable format. (<a title=\"Stablepharma Receives MHRA Approval for Phase 1 Trial of Fridge-Free Tetanus &amp; Diphtheria (Td) Vaccine - Stablepharma\" href=\"https:\/\/stablepharma.com\/stablepharma-receives-mhra-approval-phase-1-trial-of-fridge-free-td-vaccine\/?utm_source=chatgpt.com\">Stablepharma<\/a>)<\/td>\n<\/tr>\n<tr>\n<td>Vaccine candidate<\/td>\n<td>SPVX02 \u2013 Td (tetanus &amp; diphtheria) adult booster. (<a title=\"Stablepharma enters Phase 1 Clinical Trials with world-first Fridge-Free Td Vaccine - Stablepharma\" href=\"https:\/\/stablepharma.com\/work-to-launch-fridge-free-vaccine-under-way\/?utm_source=chatgpt.com\">Stablepharma<\/a>)<\/td>\n<\/tr>\n<tr>\n<td>Trial phase<\/td>\n<td>Phase 1, first\u2010in\u2010human, UK. (<a title=\"Stablepharma\u2019s fridge-free vaccine entering first-in-human UK clinical trial | BIA\" href=\"https:\/\/www.bioindustry.org\/resource\/stablepharma-s-fridge-free-vaccine-entering-first-in-human-uk-clinical-trial.html?utm_source=chatgpt.com\">bioindustry.org<\/a>)<\/td>\n<\/tr>\n<tr>\n<td>Location<\/td>\n<td>NIHR Southampton Clinical Research Facility, University Hospital Southampton. (<a title=\"World-first clinical trial launched in Southampton for a fridge-free vaccine | ITV News Meridian\" href=\"https:\/\/www.itv.com\/news\/meridian\/2025-04-28\/world-first-clinical-trial-launched-in-the-uk-for-a-fridge-free-vaccine?utm_source=chatgpt.com\">ITVX<\/a>)<\/td>\n<\/tr>\n<tr>\n<td>Stability claim<\/td>\n<td>Remains stable over multiple cycles between -20\u00b0C and +40\u00b0C. Room temperature shelf-life for clinical batch: ~18 months (pre-commercial claim). (<a title=\"Fridge-free vaccine trialled in Southampton - Healthcare Today\" href=\"https:\/\/healthcaretoday.com\/article\/fridge-free-vaccine-trialled-in-southampton?utm_source=chatgpt.com\">Healthcare Today<\/a>)<\/td>\n<\/tr>\n<tr>\n<td>Future pipeline<\/td>\n<td>Up to ~60 approved or under-development vaccines could be eligible for reformulation via the platform. (<a title=\"World-first clinical trial launched in the UK for a fridge-free vaccine | The Standard\" href=\"https:\/\/www.standard.co.uk\/news\/science\/health-southampton-world-health-organisation-university-of-southampton-wes-streeting-b1224818.html?utm_source=chatgpt.com\">The Standard<\/a>)<\/td>\n<\/tr>\n<tr>\n<td>Potential global use date<\/td>\n<td>Company hope for global use by 2027 (if trial and further development succeed). (<a title=\"World-first clinical trial launched in the UK for a fridge-free vaccine | The Standard\" href=\"https:\/\/www.standard.co.uk\/news\/science\/health-southampton-world-health-organisation-university-of-southampton-wes-streeting-b1224818.html?utm_source=chatgpt.com\">The Standard<\/a>)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr \/>\n<h3><span class=\"ez-toc-section\" id=\"What_to_watch_next_steps\"><\/span>What to watch \/ next steps<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li><strong>Safety &amp; immunogenicity outcomes<\/strong>: The Phase 1 trial will primarily test safety and tolerability (and some immunogenicity) in a small adult cohort. The results\u2014when published\u2014will be critical. Until those data are peer-reviewed, the claims remain promising but unproven.<\/li>\n<li><strong>Scale-up &amp; manufacturing<\/strong>: Even if thermostability works, manufacturing at GMP scale, regulatory approvals, and distribution logistics still need to be addressed. The company claims scalable GMP manufacturing. (<a title=\"UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus &amp; Diphtheria Vaccine - BioSpace\" href=\"https:\/\/www.biospace.com\/press-releases\/uk-company-stablepharma-ltd-enters-phase-1-clinical-trials-with-world-first-fridge-free-tetanus-diphtheria-vaccine?utm_source=chatgpt.com\">BioSpace<\/a>)<\/li>\n<li><strong>Regulatory &amp; global policy acceptance<\/strong>: Will regulatory agencies globally accept thermostable vaccines based on new formulation platforms? Will WHO prequalification recognise them? These are important for global impact.<\/li>\n<li><strong>Cost vs benefit<\/strong>: Although thermostable vaccines reduce cold\u2010chain cost, the reformulation cost and licensing must be economically viable for manufacturers and health systems.<\/li>\n<li><strong>Application to other vaccines<\/strong>: While the Td vaccine is a proof-of-concept, applying to high-profile global vaccine targets (e.g., childhood immunisations, mRNA vaccines, COVID-19 boosters) is a larger challenge.<\/li>\n<li><strong>Market dynamics &amp; access<\/strong>: A major benefit is access in low-resource settings\u2014but models for equitable distribution, pricing and manufacturing in such settings will matter.<\/li>\n<li><strong>Data transparency &amp; real-world testing<\/strong>: The durability claims (-20\u00b0C to +40\u00b0C cycles, 18-month shelf life) are strong. Independent verification and public data will boost confidence.<\/li>\n<\/ul>\n<hr \/>\n<h3><span class=\"ez-toc-section\" id=\"Comments_reflections\"><\/span>Comments &amp; reflections<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li><strong>Innovative step<\/strong>: This is one of those \u201cincremental but transformative\u201d innovations: not a new antigen, but a new <em>formulation\/ logistics<\/em> twist that could unlock large value (\u201cwhat if vaccines didn\u2019t need a fridge?\u201d).<\/li>\n<li><strong>Global health game-changer potential<\/strong>: From a global perspective, removing cold-chain burden is massive. Many low-income countries struggle with last-mile refrigeration; a fridge-free vaccine could significantly increase coverage, reduce wastage and cost.<\/li>\n<li><strong>UK biotech ecosystem strength<\/strong>: The fact that a UK company, supported by UK public funding (Innovate UK, NIHR) is leading this trial is positive for the UK\u2019s life-sciences ecosystem. It shows \u201cbeyond the big vaccines\u201d innovation is alive.<\/li>\n<li><strong>But not guaranteed success<\/strong>: The history of vaccine innovation cautions that early promise doesn\u2019t always translate into widely used products. Stability in the lab and batches doesn\u2019t always map to real\u2010world supply chain, manufacture, regulation, and distribution complexity.<\/li>\n<li><strong>Broader implications for vaccine logistics<\/strong>: If successful, this could prompt a shift in how vaccines are designed and deployed\u2014thinking about thermostability from the start, not just antigen efficacy. That might influence future vaccine development strategies (including for pandemics).<\/li>\n<li><strong>Commercial &amp; public-health intersection<\/strong>: The reformulation could open new commercial opportunities (licensing, platform technology) but also raises questions of access and pricing\u2014especially for global health. Balancing innovation with equitable access will be important.<\/li>\n<li><strong>Policy &amp; sustainability benefits<\/strong>: Reducing cold\u2010chain also means less energy use, less waste, fewer spoiled doses\u2014so there is a sustainability and cost-saving dimension that complements health benefits.<\/li>\n<li><strong>Timing is good<\/strong>: With vaccine equity, pandemic preparedness, supply-chain resilience high on global radar, the timing for such innovation is opportune. If the trial succeeds, it may accelerate interest and investment in similar formulation\/thermostability technologies.<\/li>\n<\/ul>\n<hr \/>\n<h3><span class=\"ez-toc-section\" id=\"Final_summary\"><\/span>Final summary<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The UK\u2019s launch of a \u201cfridge-free\u201d vaccine trial (SPVX02 by Stablepharma) is a noteworthy and potentially game-changing development in vaccine logistics and global health. While still early\u2014pending Phase 1 results\u2014it addresses a key bottleneck (cold-chain dependency) and holds promise for broader application. For innovators, manufacturers, global health policymakers and investors alike, it\u2019s a technology to monitor closely.<\/p>\n<p>Here are <strong>two detailed case studies<\/strong> of fridge-free vaccine trials in the UK and a commentary section on what they imply for the broader vaccine\/health-innovation ecosystem.<\/p>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Case_Study_1_Stablepharma_Ltd_%E2%80%93_SPVX02_Tetanus_Diphtheria\"><\/span>Case Study 1: Stablepharma Ltd \u2013 SPVX02 (Tetanus &amp; Diphtheria)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><img decoding=\"async\" src=\"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.clinicaltrialsarena.com\/wp-content\/uploads\/sites\/22\/2025\/04\/Stablevax.png\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/stablepharma.com\/wp-content\/uploads\/2022\/05\/key.png\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/stablepharma.com\/wp-content\/uploads\/2024\/05\/Pipeline-graph-jpeg-scaled.jpg\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.nihr.ac.uk\/sites\/corporate\/files\/styles\/social_share\/public\/acquiadam-image\/2025-04\/fridge%20free%20vaccine%20southampton%20crf.jpg?h=dd1b06b1\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ichef.bbci.co.uk\/images\/ic\/640x360\/p0l73yrg.jpg\" alt=\"Image\" \/><\/p>\n<p><strong>Background &amp; Technology<\/strong><\/p>\n<ul>\n<li>Stablepharma, a UK-based biotech, has developed a technology platform called StablevaX\u2122 which reformulates vaccines\/biologics into <strong>thermostable<\/strong> formats that no longer require the conventional \u201ccold chain\u201d (refrigeration at 2-8 \u00b0C or freezing). (<a title=\"Stablepharma's fridge-free vaccine entering first-in-human UK ...\" href=\"https:\/\/www.bioindustry.org\/resource\/stablepharma-s-fridge-free-vaccine-entering-first-in-human-uk-clinical-trial.html?utm_source=chatgpt.com\">bioindustry.org<\/a>)<\/li>\n<li>According to publicly-available data, their lead candidate SPVX02 (a tetanus &amp; diphtheria (Td) adult booster) remains stable at room temperature (up to ~30 \u00b0C) with an 18-month shelf life for the clinical batch. It also withstands extreme temperature fluctuations (\u221220 \u00b0C to +40 \u00b0C) in stability testing. (<a title=\"Stablepharma enters Phase 1 Clinical Trials with world-first Fridge ...\" href=\"https:\/\/stablepharma.com\/work-to-launch-fridge-free-vaccine-under-way\/?utm_source=chatgpt.com\">Stablepharma<\/a>)<\/li>\n<\/ul>\n<p><strong>Trial Details<\/strong><\/p>\n<ul>\n<li>The UK regulator Medicines and Healthcare products Regulatory Agency (MHRA) approved the Phase 1 first-in-human trial for SPVX02. (<a title=\"Stablepharma's fridge-free vaccine entering first-in-human UK ...\" href=\"https:\/\/www.bioindustry.org\/resource\/stablepharma-s-fridge-free-vaccine-entering-first-in-human-uk-clinical-trial.html?utm_source=chatgpt.com\">bioindustry.org<\/a>)<\/li>\n<li>The trial is being conducted at the NIHR Southampton Clinical Research Facility at University Hospital Southampton under lead investigator Saul Faust in partnership with Dr Karen O\u2019Hanlon (Stablepharma). (<a title=\"Press releases - world-first trial launched for fridge-free vaccine\" href=\"https:\/\/www.uhs.nhs.uk\/whats-new\/press-releases\/world-first-trial-launched-for-fridge-free-vaccine?utm_source=chatgpt.com\">uhs.nhs.uk<\/a>)<\/li>\n<li>First participant was dosed on 15 April 2025. The Phase 1 trial is expected to complete by Q3 2025, with initial data by end of 2025. (<a title=\"Stablepharma enters Phase 1 Clinical Trials with world-first Fridge ...\" href=\"https:\/\/stablepharma.com\/work-to-launch-fridge-free-vaccine-under-way\/?utm_source=chatgpt.com\">Stablepharma<\/a>)<\/li>\n<\/ul>\n<p><strong>Why it matters<\/strong><\/p>\n<ul>\n<li>The \u201ccold chain\u201d (continuous refrigeration\/tracking) is a major global barrier: the World Health Organization (WHO) estimates up to <strong>50% of vaccines are wasted<\/strong> annually because of storage\/distribution issues. (<a title=\"World-first clinical trial for 'room temperature' vaccines launched in UK\" href=\"https:\/\/www.the-independent.com\/news\/health\/vaccine-trial-uk-fridge-free-room-temperature-southampton-b2740928.html?utm_source=chatgpt.com\">The Independent<\/a>)<\/li>\n<li>If SPVX02 and its underlying platform perform as claimed, you could see major improvements in <strong>vaccine access<\/strong>, <strong>equity<\/strong>, <strong>cost-reduction<\/strong>, and <strong>logistics<\/strong> especially in low-resource or remote settings.<\/li>\n<li>The UK is positioning itself as a leader in this area: the government is publicly supporting the trial. (<a title=\"World-first clinical trial for 'room temperature' vaccines launched in UK\" href=\"https:\/\/www.the-independent.com\/news\/health\/vaccine-trial-uk-fridge-free-room-temperature-southampton-b2740928.html?utm_source=chatgpt.com\">The Independent<\/a>)<\/li>\n<\/ul>\n<p><strong>Key metrics &amp; claims<\/strong><\/p>\n<ul>\n<li>Temperature stability: fully potent after three cycles of \u221220 \u00b0C to +40 \u00b0C. (<a title=\"Stablepharma begins first-in-human trial of \u201cworld-first\u201d fridge-free ...\" href=\"https:\/\/www.clinicaltrialsarena.com\/news\/stablepharma-first-in-human-trial-fridge-free-vaccine\/?utm_source=chatgpt.com\">clinicaltrialsarena.com<\/a>)<\/li>\n<li>Shelf life: 18 months at up to ~30 \u00b0C for the clinical batch. (<a title=\"Stablepharma enters Phase 1 Clinical Trials with world-first Fridge ...\" href=\"https:\/\/stablepharma.com\/work-to-launch-fridge-free-vaccine-under-way\/?utm_source=chatgpt.com\">Stablepharma<\/a>)<\/li>\n<li>Pipeline potential: Up to ~60 other existing temperature-sensitive vaccines could be reformulated via the platform. (<a title=\"Stablepharma begins first-in-human trial of \u201cworld-first\u201d fridge-free ...\" href=\"https:\/\/www.clinicaltrialsarena.com\/news\/stablepharma-first-in-human-trial-fridge-free-vaccine\/?utm_source=chatgpt.com\">clinicaltrialsarena.com<\/a>)<\/li>\n<\/ul>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Case_Study_2_Regional_Infrastructure_Lens_%E2%80%93_UK_Government-backed_Programme_Cold_Chain_Disruption\"><\/span>Case Study 2: Regional \/ Infrastructure Lens \u2013 UK Government-backed Programme &amp; Cold Chain Disruption<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><img decoding=\"async\" src=\"https:\/\/www.who.int\/images\/default-source\/departments\/immunization-ivb\/supply-chain\/job-aide_safe-disposal-of-c19-waste_poster_l4.jpg?sfvrsn=5d4628f_3\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/assets.publishing.service.gov.uk\/media\/646cc54c382a5100139fc5dd\/VaccineWastagePieChart.svg\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/static.wixstatic.com\/media\/178f68_a827da6528d14e75826b4b30c120184f~mv2.jpg\/v1\/crop\/x_0%2Cy_182%2Cw_5581%2Ch_3357\/fill\/w_280%2Ch_138%2Cal_c%2Cq_80%2Cusm_0.66_1.00_0.01%2Cenc_avif%2Cquality_auto\/IMG_0855%201.jpg\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.southampton.ac.uk\/img\/ctu\/News%20release%20images\/CRF%20NIHR%20funding%20-%20CRN%20photos%20%28resized%29.jpg?csf=1&amp;e=7tVeS1&amp;web=1\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/s.yimg.com\/ny\/api\/res\/1.2\/cZ9SfNHT_TGMrXDa266AdA--\/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMA--\/https%3A\/\/media.zenfs.com\/en\/globenewswire.com\/9698e31de192212a687a64dd5913d7c0\" alt=\"Image\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.clinicaltrialsarena.com\/wp-content\/uploads\/sites\/22\/2025\/04\/Stablevax.png\" alt=\"Image\" \/><\/p>\n<p><strong>Context<\/strong><\/p>\n<ul>\n<li>The cold-chain requirement (2-8 \u00b0C, sometimes \u221220 \u00b0C or lower) is costly: transport, storage, monitoring, waste due to breaks in chain. The UK\u2019s funding programmes (via Innovate UK, NIHR etc) have supported innovation to overcome these logistic bottlenecks. For example, Stablepharma\u2019s trial is part-funded via UK government schemes. (<a title=\"Stablepharma enters Phase 1 Clinical Trials with world-first Fridge ...\" href=\"https:\/\/stablepharma.com\/work-to-launch-fridge-free-vaccine-under-way\/?utm_source=chatgpt.com\">Stablepharma<\/a>)<\/li>\n<li>The UK\u2019s NIHR Southampton facility is hosting the \u201cworld-first\u201d human trial of a fridge-free vaccine (SPVX02) and emphasises the potential global impact of such tech. (<a title=\"World-first trial launched for fridge-free vaccine\" href=\"https:\/\/southamptoncrf.nihr.ac.uk\/post\/world-first-trial-launched-for-fridge-free-vaccine?utm_source=chatgpt.com\">CRF<\/a>)<\/li>\n<\/ul>\n<p><strong>Why this is a system-level case<\/strong><\/p>\n<ul>\n<li>It shows how innovation is not only about new antigens\/immunology, but also <strong>formulation &amp; logistics<\/strong>.<\/li>\n<li>It underscores the UK ecosystem: biotech firms + national research institutes + government backing + NHS infrastructure collaborating.<\/li>\n<li>If successful, this kind of innovation could ripple across many vaccines (not just new ones) by making existing ones easier to store\/distribute.<\/li>\n<\/ul>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Commentary_%E2%80%93_What_the_Rise_of_Fridge-Free_Vaccines_Means\"><\/span>Commentary \u2013 What the Rise of Fridge-Free Vaccines Means<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>\u00a0Positive implications<\/strong><\/p>\n<ul>\n<li><strong>Increased access &amp; equity<\/strong>: Reducing reliance on the cold chain means vaccines could reach more remote, resource-constrained areas; distribution becomes simpler and less costly.<\/li>\n<li><strong>Cost &amp; waste reduction<\/strong>: Less need for refrigeration, lower energy\/transport logistics, fewer spoiled vaccines. That saves money and improves public-health return on investment.<\/li>\n<li><strong>UK innovation leadership<\/strong>: The UK is showing early institutional leadership in this niche\u2014potential export strength, biotech growth, global health credentials.<\/li>\n<li><strong>Systemic innovation<\/strong>: Not just new vaccines, but existing ones reformulated\u2014this multiplies impact. The case of up to 60 candidate vaccines for reformulation shows this potential.<\/li>\n<\/ul>\n<p><strong>\u00a0Key caveats \/ challenges<\/strong><\/p>\n<ul>\n<li><strong>Proof-of-concept is early<\/strong>: Phase 1 trials test safety\/immunogenicity primarily; broader efficacy, commercial scale-up, regulatory approvals remain to happen. Until then, claims remain promising rather than proven.<\/li>\n<li><strong>Manufacturing &amp; supply-chain still matter<\/strong>: Even if thermostability is achieved, large-scale GMP manufacturing, regulatory acceptance, global distribution (licensing, local regulation) must be addressed.<\/li>\n<li><strong>Cost of reformulation\/licensing<\/strong>: Converting an existing vaccine into a new format may incur R&amp;D\/manufacturing cost. The economics must make sense for pharma manufacturers and global health purchasers.<\/li>\n<li><strong>Regulatory &amp; acceptance issues<\/strong>: Regulatory bodies in different countries, WHO pre-qualification, national immunisation programmes will need evidence of performance, safety, cost-benefit.<\/li>\n<li><strong>Not all vaccines may be amenable<\/strong>: Some vaccine types or biologics may be harder to thermostabilise; cold chain may still be required for many. So it\u2019s a <strong>significant improvement<\/strong>, but not a universal panacea.<\/li>\n<\/ul>\n<p><strong>\u00a0Strategic implications<\/strong><\/p>\n<ul>\n<li><strong>For biotech\/start-ups<\/strong>: Focus on formulation innovation (thermostability) as a high-impact differentiator. Partner with established vaccine manufacturers, global health agencies, regulators early.<\/li>\n<li><strong>For global health policy<\/strong>: Investment in these kinds of innovations helps reach underserved populations and achieves immunisation goals (e.g., WHO\u2019s Universal Health Coverage). Governments and NGOs should monitor and invest in these pipeline technologies.<\/li>\n<li><strong>For manufacturing\/investment<\/strong>: Investors and manufacturers should view this as an emerging category: vaccines that avoid cold chain present a new market dynamic (e.g., in low-resource countries, or for stockpiling\/emergency use).<\/li>\n<li><strong>For national biotech strategy<\/strong>: Countries that develop and export this capability may gain a competitive advantage\u2014not only scientifically but economically (manufacture, export, licensing). The UK is aiming for that position.<\/li>\n<\/ul>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Final_Take-away\"><\/span>Final Take-away<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The trial of the fridge-free vaccine (SPVX02) in the UK is <strong>not just an incremental advancement<\/strong>, but has the potential to reshape vaccine delivery logistics globally. It addresses a major barrier\u2014the cold chain\u2014one that contributes to high waste, high cost, and inequitable access. The UK case shows how formulation innovation + national support + clinical infrastructure converge.<\/p>\n<p>However: the innovation still has to <strong>prove itself<\/strong> (safety, efficacy, scalability, cost-viability, global acceptance). If it succeeds, it could open a new chapter in vaccines \u2014 simpler distribution, broader access, lower waste, and maybe lower cost.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li><\/li>\n<\/ul>\n<ul>\n<li><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stablepharma Ltd\u2019s \u201cFridge-Free\u201d Vaccine Trials in the UK Here\u2019s a detailed breakdown of the development and significance of fridge-free vaccines in the UK. What is&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,6],"tags":[],"class_list":["post-946504","post","type-post","status-publish","format-standard","hentry","category-gb-news","category-uk-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Rise of Fridge-Free Vaccines: Trials in the UK - UK News &amp; Updates<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Rise of Fridge-Free Vaccines: Trials in the UK - UK News &amp; Updates\" \/>\n<meta property=\"og:description\" content=\"Stablepharma Ltd\u2019s \u201cFridge-Free\u201d Vaccine Trials in the UK Here\u2019s a detailed breakdown of the development and significance of fridge-free vaccines in the UK. What is...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/\" \/>\n<meta property=\"og:site_name\" content=\"UK News &amp; Updates\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-01T13:11:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/5529805dee92503827c0c27ed13d55a3\"},\"headline\":\"The Rise of Fridge-Free Vaccines: Trials in the UK\",\"datePublished\":\"2025-11-01T13:11:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/\"},\"wordCount\":1940,\"publisher\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/#organization\"},\"image\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg\",\"articleSection\":[\"GB News\",\"UK News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/\",\"url\":\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/\",\"name\":\"The Rise of Fridge-Free Vaccines: Trials in the UK - UK News &amp; Updates\",\"isPartOf\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg\",\"datePublished\":\"2025-11-01T13:11:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#primaryimage\",\"url\":\"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg\",\"contentUrl\":\"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ukpostcode.org\/content\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Rise of Fridge-Free Vaccines: Trials in the UK\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#website\",\"url\":\"https:\/\/ukpostcode.org\/content\/\",\"name\":\"UK News &amp; Updates\",\"description\":\"UK Post Code\",\"publisher\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ukpostcode.org\/content\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#organization\",\"name\":\"UK News &amp; Updates\",\"url\":\"https:\/\/ukpostcode.org\/content\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ukpostcode.org\/content\/wp-content\/uploads\/2023\/09\/cropped-uk-logo-1.png\",\"contentUrl\":\"https:\/\/ukpostcode.org\/content\/wp-content\/uploads\/2023\/09\/cropped-uk-logo-1.png\",\"width\":307,\"height\":85,\"caption\":\"UK News &amp; Updates\"},\"image\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/5529805dee92503827c0c27ed13d55a3\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6aac6e3af4be1d6689e924bbaccd84fc0cc6c5f6680490dc6f0a1f09b87d57f1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6aac6e3af4be1d6689e924bbaccd84fc0cc6c5f6680490dc6f0a1f09b87d57f1?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/ukpostcode.org\/content\"],\"url\":\"https:\/\/ukpostcode.org\/content\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Rise of Fridge-Free Vaccines: Trials in the UK - UK News &amp; Updates","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/","og_locale":"en_US","og_type":"article","og_title":"The Rise of Fridge-Free Vaccines: Trials in the UK - UK News &amp; Updates","og_description":"Stablepharma Ltd\u2019s \u201cFridge-Free\u201d Vaccine Trials in the UK Here\u2019s a detailed breakdown of the development and significance of fridge-free vaccines in the UK. What is...","og_url":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/","og_site_name":"UK News &amp; Updates","article_published_time":"2025-11-01T13:11:18+00:00","og_image":[{"url":"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg","type":"","width":"","height":""}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#article","isPartOf":{"@id":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/"},"author":{"name":"admin","@id":"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/5529805dee92503827c0c27ed13d55a3"},"headline":"The Rise of Fridge-Free Vaccines: Trials in the UK","datePublished":"2025-11-01T13:11:18+00:00","mainEntityOfPage":{"@id":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/"},"wordCount":1940,"publisher":{"@id":"https:\/\/ukpostcode.org\/content\/#organization"},"image":{"@id":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg","articleSection":["GB News","UK News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/","url":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/","name":"The Rise of Fridge-Free Vaccines: Trials in the UK - UK News &amp; Updates","isPartOf":{"@id":"https:\/\/ukpostcode.org\/content\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#primaryimage"},"image":{"@id":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg","datePublished":"2025-11-01T13:11:18+00:00","breadcrumb":{"@id":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#primaryimage","url":"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg","contentUrl":"https:\/\/www.bioindustry.org\/static\/e8f5e4d7-fc67-4ff1-b5e99d2a68ec4817\/opengraphimage_83f4e8796336604b59d7216d0ecd81a5_4a7c7e45a350\/SPVX02-CT-Batch-Vial.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/ukpostcode.org\/content\/the-rise-of-fridge-free-vaccines-trials-in-the-uk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ukpostcode.org\/content\/"},{"@type":"ListItem","position":2,"name":"The Rise of Fridge-Free Vaccines: Trials in the UK"}]},{"@type":"WebSite","@id":"https:\/\/ukpostcode.org\/content\/#website","url":"https:\/\/ukpostcode.org\/content\/","name":"UK News &amp; Updates","description":"UK Post Code","publisher":{"@id":"https:\/\/ukpostcode.org\/content\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ukpostcode.org\/content\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ukpostcode.org\/content\/#organization","name":"UK News &amp; Updates","url":"https:\/\/ukpostcode.org\/content\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ukpostcode.org\/content\/#\/schema\/logo\/image\/","url":"https:\/\/ukpostcode.org\/content\/wp-content\/uploads\/2023\/09\/cropped-uk-logo-1.png","contentUrl":"https:\/\/ukpostcode.org\/content\/wp-content\/uploads\/2023\/09\/cropped-uk-logo-1.png","width":307,"height":85,"caption":"UK News &amp; Updates"},"image":{"@id":"https:\/\/ukpostcode.org\/content\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/5529805dee92503827c0c27ed13d55a3","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6aac6e3af4be1d6689e924bbaccd84fc0cc6c5f6680490dc6f0a1f09b87d57f1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6aac6e3af4be1d6689e924bbaccd84fc0cc6c5f6680490dc6f0a1f09b87d57f1?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/ukpostcode.org\/content"],"url":"https:\/\/ukpostcode.org\/content\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/posts\/946504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/comments?post=946504"}],"version-history":[{"count":1,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/posts\/946504\/revisions"}],"predecessor-version":[{"id":946505,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/posts\/946504\/revisions\/946505"}],"wp:attachment":[{"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/media?parent=946504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/categories?post=946504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/tags?post=946504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}